INOZYME PHARMA INC. -
5.2100
07-October-24 14:59:31
15 minutes delayed
Stocks
+0.0400
+0.77%
Today's range
5.1200 - 5.2800
ISIN
N/A
Source
NASDAQ
-
Inozyme Pharma to Participate in Upcoming Investor Conferences
09 Nov 2023 07:30:00 By Nasdaq GlobeNewswire
-
Inozyme Pharma Reports Third Quarter 2023 Financial Results and Provides Business Highlights
07 Nov 2023 07:30:00 By Nasdaq GlobeNewswire
-
Inozyme Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
03 Nov 2023 15:15:00 By Nasdaq GlobeNewswire
-
Inozyme Pharma Announces Presentation at the American Society of Nephrology (ASN) Kidney Week 2023
26 Oct 2023 07:30:00 By Nasdaq GlobeNewswire
-
10 Oct 2023 07:30:00 By Nasdaq GlobeNewswire
-
06 Oct 2023 07:30:00 By Nasdaq GlobeNewswire
-
26 Sep 2023 06:30:00 By Nasdaq GlobeNewswire
-
Inozyme Pharma to Host Virtual Investor and Analyst Event on Sep. 26, 2023
20 Sep 2023 07:30:00 By Nasdaq GlobeNewswire
-
Inozyme Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
06 Sep 2023 07:30:00 By Nasdaq GlobeNewswire
-
Inozyme Pharma to Present at the H.C. Wainwright 25th Annual Global Investment Conference
05 Sep 2023 07:30:00 By Nasdaq GlobeNewswire
-
Inozyme Pharma Reports Second Quarter 2023 Financial Results and Provides Business Highlights
08 Aug 2023 07:30:00 By Nasdaq GlobeNewswire
-
Inozyme Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
03 Aug 2023 15:01:00 By Nasdaq GlobeNewswire
-
Inozyme Pharma, Inc. Announces Closing of Public Offering of Common Stock
01 Aug 2023 15:01:00 By Nasdaq GlobeNewswire
-
Inozyme Pharma, Inc. Announces Pricing of Public Offering of Common Stock
27 Jul 2023 22:20:15 By Nasdaq GlobeNewswire
-
Inozyme Pharma, Inc. Announces Proposed Offering of Common Stock
27 Jul 2023 15:33:08 By Nasdaq GlobeNewswire
-
26 Jul 2023 06:30:00 By Nasdaq GlobeNewswire
-
Inozyme Pharma to Provide ENPP1 Deficiency Program Update on July 26, 2023
19 Jul 2023 07:30:00 By Nasdaq GlobeNewswire
-
Inozyme Pharma Announces Dosing of First Infant with ENPP1 Deficiency in a Phase 1b Trial of INZ-701
27 Jun 2023 07:30:00 By Nasdaq GlobeNewswire
-
Inozyme Pharma to Present at the Jefferies Healthcare Conference
02 Jun 2023 06:30:00 By Nasdaq GlobeNewswire
-
Inozyme Pharma Reports First Quarter 2023 Financial Results and Provides Business Highlights
09 May 2023 07:30:00 By Nasdaq GlobeNewswire